Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closures

HN.4 A Phase II study of cisplatin and gemcitabine in patiens with locally advanced/recurrent or metastatic malignant salivary gland tumours, was closed to further accrual on May 5, 2008.

http://www.ctg.queensu.ca/trials/head_neck/hn4/hn4.html

PA.2 (ESPAC-3) Phase III adjuvant trial in pancreatic cancer comparing (1) 5FU and D-L folinic acid vs (2) gemcitabine vs (3) no adjuvant treatment, was closed to further accrual on May 6, 2008.

http://www.ctg.queensu.ca/trials/gastro-intestinal/pa2/pa2.html

BL.8 (EORTC 30994) Randomized phase III trial comparing immediate vs deferred chemotherapy after radical cystectomy in patients with PT3-PT4, and/or N+M0 transitional cell carcinoma of the bladder, was closed to further accrual on May 9, 2008.

http://www.ctg.queensu.ca/trials/genito-urinary/bl8/bl8.html